Related Experiment Video
Updated: May 10, 2026

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
Coping with modesty during radiotherapy for breast cancer: a multicentric study
Luca Boldrini1,2, Loredana Dinapoli3, Edda Boccia1
1UOC di Radioterapia Oncologica, Dipartimento Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Breast Cancer Research and Treatment
|May 18, 2024
Summary
Modesty is a significant concern for breast cancer patients undergoing radiotherapy (RT). Addressing patient comfort and privacy can enhance their overall treatment experience.
Area of Science:
- Oncology
- Radiotherapy
- Patient Experience
Background:
- Breast cancer is the most common cancer in women, with radiotherapy (RT) being a key treatment modality.
- Patient well-being during RT involves physical comfort and emotional support, including considerations of modesty.
Purpose of the Study:
- To assess modesty concerns among breast cancer patients undergoing RT.
- To gather patient suggestions for improving privacy and comfort during treatment.
Main Methods:
- A questionnaire was administered to 555 breast cancer patients undergoing adjuvant RT in Italy.
- The survey evaluated comfort levels regarding modesty, relationships with healthcare professionals, religious views, and sexuality.
Main Results:
- Modesty was a prevalent concern, linked to general life discomforts.
- Patients preferred same-sex healthcare workers, especially younger individuals.
- Surgical approach (mastectomy vs. quadrantectomy) did not significantly impact modesty perceptions.
Conclusions:
- Modesty is a critical factor in the RT experience for breast cancer patients.
- Interventions addressing modesty, communication, and body image support are needed.
- This research highlights the importance of patient-centered care in radiotherapy.
More Related Videos
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

